IMN || Across Specialties

DDT metabolite may be associated with risk for Alzheimer’s

Posted on: 27/01/2014 - 21:00

A metabolite of the pesticide DDT – banned in the United States since 1972 – was associated with late-onset Alzheimer’s disease in a small, case-control study. Levels of the chemical...

Field of Interest: Geriatrics

Type: News Item

Two Alzheimer’s immunotherapy drugs flunk in four studies

Posted on: 22/01/2014 - 22:00

Two investigational Alzheimer’s immunotherapies failed to show any benefit in a series of phase III trials comprising more than 4,000 patients. Neither bapineuzumab, which targets soluble and...

Field of Interest: Geriatrics

Type: News Item

Trial immunosuppressive therapy benefits outweigh long-term lymphoma risks in IBD

Posted on: 22/01/2014 - 18:40

HOLLYWOOD, FLA. – The benefits of short-term trial immunosuppressive therapy outweigh the risks in inflammatory bowel disease, but certain patient populations require more vigilance than others, Dr....

Field of Interest: Gastroentero...

Type: News Item

The price and cost of hepatitis C treatment

Posted on: 16/01/2014 - 19:55

Chronic hepatitis C virus (HCV) infection is a major cause of liver disease affecting 180 million people globally. HCV infection, both silent and slow in its revelation, and devastating in its...

Field of Interest: Gastroentero...

Type: News Item

Dual-vaccine therapy prolonged survival in pancreatic cancer

Posted on: 16/01/2014 - 18:35

SAN FRANCISCO – Serial administration of two vaccines that stimulate the immune response to pancreatic cancer antigens prolonged survival of metastatic disease by about 2 months, according to Dr....

Field of Interest: Gastroentero...

Type: News Item

Daclatasvir-sofosbuvir combo scores in resistant hepatitis C

Posted on: 15/01/2014 - 22:00

A combined regimen of daclatasvir and sofosbuvir achieved sustained virologic response rates greater than 90% in an industry-sponsored trial involving patients with chronic HCV, according to study...

Field of Interest: Gastroentero...

Type: News Item

Expanded genetic testing better predicts panitumumab plus chemo response

Posted on: 15/01/2014 - 19:50

SAN FRANCISCO – Patients with metastatic colorectal cancer should be broadly tested for RAS mutations before being treated with panitumumab, according to new data from a <link...

Field of Interest: Gastroentero...

Type: News Item

Despite benefits, ‘bundling’ endoscopy is not norm

Posted on: 01/01/2014 - 05:01

In more than one-third of cases, same-day bidirectional endoscopy is not performed in Medicare beneficiaries, despite the fact that so-called "bundled" endoscopies offer significant cost...

Field of Interest: Gastroentero...

Type: News Item

Low-FODMAP diet reduced IBS symptoms

Posted on: 01/01/2014 - 05:01

Diets low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols reduced functional gastrointestinal symptoms in patients with irritable bowel syndrome. The finding, published...

Field of Interest: Gastroentero...

Type: News Item

Golimumab maintains response in UC

Posted on: 01/01/2014 - 05:01

Subcutaneous golimumab induces and maintains clinical response in ulcerative colitis, according to two studies in the January issue of Gastroenterology. <link...

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters